Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$0.17 - $765.0 $6,669 - $30 Million
39,230 Added 25.43%
193,505 $30,000
Q2 2022

Aug 09, 2022

SELL
$0.27 - $0.71 $20,248 - $53,246
-74,995 Reduced 32.71%
154,275 $45,000
Q1 2022

May 17, 2022

BUY
$0.38 - $1.07 $37,647 - $106,008
99,073 Added 76.09%
229,270 $162,000
Q4 2021

Feb 17, 2022

BUY
$1.03 - $2.48 $94,018 - $226,374
91,280 Added 234.55%
130,197 $135,000
Q3 2021

Nov 12, 2021

BUY
$2.14 - $4.95 $83,282 - $192,639
38,917 New
38,917 $88,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.